NEW YORK, NY, December 13, 2023 – ReShape Lifesciences (Nasdaq: RSLS) has been granted FDA approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX.
NEW YORK, NY, December 13, 2023 – US equities closed mostly higher on Tuesday as the S&P set a fresh year-to-date high, finishing the day
NEW YORK, NY, December 13, 2023 – Quoin Pharmaceuticals (Nasdaq: QNRX) has received U.S. Food and Drug Administration (FDA) clearance to implement several protocol amendments to its
Leading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech and Media IPO market to
NEW YORK, NY, December 12, 2023 – An immersive technology platform company, Glimpse recently announced its plans for a strategic shift from current immersive technologies that include
NEW YORK, NY, December 11, 2023 – The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a Phase 2 clinical trial
NEW YORK, NY, December 11, 2023 – Shares in the casual dining chain, Shake Shack ($SHAK) jumped nearly 10% today after the company provided a financial outlook
NEW YORK, NY, December 07, 2023 – In the ever-evolving landscape of technological innovation, the Glimpse Group, Inc. (VRAR) emerges as a beacon of creativity
NEW YORK, NY, December 07, 2023 – PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd. (Nasdaq: KMDA), a commercial-stage global
NEW YORK, NY, December 07, 2023 – US equities are settling mostly higher in Thursday midday trading, with big tech broadly higher as Google ($GOOG)
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
